Hyperosmolar nonketotic diabetic coma in the elderly
Hyperosmotic nonketotic diabetic coma (abbreviated as hyperosmotic coma or hyperglycemia-dehydration syndrome) is a serious acute complication of diabetes. Its clinical features are severe hyperglycemia, dehydration, and increased plasma osmotic pressure without obvious ketoacidosis. Patients often have impaired consciousness or coma. The disease has a high mortality rate and should be treated with sufficient vigilance, timely diagnosis and effective treatment.
-
Site of disease:
Pancreas whole body -
Infectious :
Not contagious -
Frequent population:
Elderly population -
Related symptoms:
Infection-induced coma hyperosmotic coma slow reaction high fever disordered speech
Related Drugs
Qiwei Digu Capsule
Manufacturer:
Arura Tibetan MEDICINE Co., Ltd.
Jiangtangning Capsules
Manufacturer:
Bi Zhi Gao Pharmaceutical Co., Ltd.
Compound Sodium Chloride Injection
Indication: ① Water loss due to various reasons, including hypotonic, isotonic and hypertonic water loss; ② Hyperosmotic non-ketotic coma, the use of isotonic or hypotonic sodium chloride can correct water loss and hyperosmotic state; ③ Hypochloremic metabolic alkalosis. When the patient cannot eat or eats less for some reason and needs to supplement the daily physiological needs, sodium chloride injection or compound sodium chloride injection can generally be given. Because this product contains very little potassium, hypokalemia needs to be supplemented as needed
Manufacturer:
Sichuan Kelun Pharmaceutical Co., Ltd.
Weikangling Capsules
Manufacturer:
Jilin Fuhui Pharmaceutical Co., Ltd.
Metformin and Glibenclamide Tablets (Ⅰ)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by simple diet control and/or exercise therapy. 2. Can be used as a second-line medication for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by single sulfonylurea or metformin hydrochloride therapy.
Manufacturer:
XI'AN HAIXIN Pharmaceutical Co., Ltd.
Pioglitazone Hydrochloride Tablets
Indication: For patients with type 2 diabetes (non-insulin-dependent diabetes mellitus, NIDDM), pioglitazone hydrochloride can be combined with diet control and physical exercise to improve blood sugar control. Pioglitazone hydrochloride can be used alone, or in combination with sulfonylurea, metformin or insulin when diet control, physical exercise and monotherapy cannot satisfactorily control blood sugar.
Related Ingredients
-
1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone list
7226-23-5 -
Calcium sulfate dihydrate list
10101-41-4 -
Sodium chloride list
7647-14-5 -
Potassium chloride list
7447-40-7 -
Calcium chloride list
10043-52-4